Invention Grant
- Patent Title: Method of producing recombinant high molecular weight vWF in cell culture
-
Application No.: US17086072Application Date: 2020-10-30
-
Publication No.: US11780904B2Publication Date: 2023-10-10
- Inventor: Leopold Grillberger , Manfred Reiter , Wolfgang Mundt
- Applicant: Takeda Pharmaceutical Company Limited
- Applicant Address: JP Osaka
- Assignee: Takeda Pharmaceutical Company Limited
- Current Assignee: Takeda Pharmaceutical Company Limited
- Current Assignee Address: JP Osaka
- Agency: Morgan, Lewis & Bockius LLP
- The original application number of the division: US16125141 2018.09.07
- Main IPC: C07K14/755
- IPC: C07K14/755 ; C12N9/64 ; A61K9/00 ; A61K38/36 ; A61K38/37 ; C12P21/00 ; A61K38/00

Abstract:
Among other aspects, the present invention relates to cell culture conditions for producing high molecular weight vWF, in particular, highly multimericWF with a high specific activity and ADAMTS13 with a high specific activity. The cell culture conditions of the present invention can include, for example, a cell culture medium with an increased copper concentration and/or cell culture supernatant with a low ammonium (NH4+) concentration. The present invention also provides methods for cultivating cells in the cell culture conditions to express high molecular weight vWF and rA13 having high specific activities.
Public/Granted literature
- US20210115110A1 METHOD OF PRODUCING RECOMBINANT HIGH MOLECULAR WEIGHT vWF IN CELL CULTURE Public/Granted day:2021-04-22
Information query